Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia.

Huttner A, Albrich WC, Bochud PY, Gayet-Ageron A, Rossel A, Dach EV, Harbarth S, Kaiser L.

BMJ Open. 2017 Jul 13;7(7):e017996. doi: 10.1136/bmjopen-2017-017996.

2.

Nosocomial and Community-Acquired Spontaneous Bacterial Peritonitis in patients with liver cirrhosis in China: Comparative Microbiology and Therapeutic Implications.

Shi L, Wu D, Wei L, Liu S, Zhao P, Tu B, Xie Y, Liu Y, Wang X, Liu L, Zhang X, Xu Z, Wang F, Qin E.

Sci Rep. 2017 Apr 6;7:46025. doi: 10.1038/srep46025. Erratum in: Sci Rep. 2017 Jul 27;7:46868.

3.

Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.

Sánchez E, Nieto JC, Vidal S, Santiago A, Martinez X, Sancho FJ, Sancho-Bru P, Mirelis B, Corominola H, Juárez C, Manichanh C, Guarner C, Soriano G.

Sci Rep. 2017 Apr 3;7:45712. doi: 10.1038/srep45712.

4.

Serum C-Reactive Protein in Children with Liver Disease and Ascites.

Kalvandi G, Honar N, Geramizadeh B, Ataollahi M, Rahmani A, Javaherizadeh H.

Hepat Mon. 2016 Jul 23;16(8):e38973. eCollection 2016 Aug.

5.

Ascitic Fluid High Sensitive C-Reactive Protein (hs-CRP). A Prognostic Marker in Cirrhosis with Spontaneous Bacterial Peritonitis.

Kadam N, Acharya S, Shukla S, Gupta K.

J Clin Diagn Res. 2016 Apr;10(4):OC20-4. doi: 10.7860/JCDR/2016/17931.7610. Epub 2016 Apr 1.

6.

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK.

Clin Infect Dis. 2016 May 15;62(10):e51-77. doi: 10.1093/cid/ciw118. Epub 2016 Apr 13.

7.

Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.

Gjini E, Brito PH.

PLoS Comput Biol. 2016 Apr 14;12(4):e1004857. doi: 10.1371/journal.pcbi.1004857. eCollection 2016 Apr.

8.

Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.

Vogt A, Reuken PA, Stengel S, Stallmach A, Bruns T.

World J Gastroenterol. 2016 Mar 21;22(11):3275-84. doi: 10.3748/wjg.v22.i11.3275.

9.

The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent.

Afinogenova Y, Tapper EB.

Gastroenterol Rep (Oxf). 2015 Aug;3(3):216-21. doi: 10.1093/gastro/gov032. Epub 2015 Jul 15.

10.

Management of cirrhotic ascites.

Pedersen JS, Bendtsen F, Møller S.

Ther Adv Chronic Dis. 2015 May;6(3):124-37. doi: 10.1177/2040622315580069. Review.

11.

Gut microbiota-related complications in cirrhosis.

Gómez-Hurtado I, Such J, Sanz Y, Francés R.

World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624. Review.

12.

Ascites and spontaneous bacterial peritonitis: recommendations from two United States centers.

Sundaram V, Manne V, Al-Osaimi AM.

Saudi J Gastroenterol. 2014 Sep-Oct;20(5):279-87. doi: 10.4103/1319-3767.141686. Review.

13.

Cirrhosis and its complications: evidence based treatment.

Nusrat S, Khan MS, Fazili J, Madhoun MF.

World J Gastroenterol. 2014 May 14;20(18):5442-60. doi: 10.3748/wjg.v20.i18.5442. Review.

14.

Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker.

Lim TS, Kim BK, Lee JW, Lee YK, Chang S, Kim SU, Kim DY, Ahn SH, Han KH, Chon CY, Park JY.

PLoS One. 2014 Jan 23;9(1):e86884. doi: 10.1371/journal.pone.0086884. eCollection 2014.

15.

Pathogenesis and management of alcoholic liver cirrhosis: a review.

Huang YW, Yang SS, Kao JH.

Hepat Med. 2011 Dec 24;3:1-11. doi: 10.2147/HMER.S10265. Review.

16.

A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient.

Maeda A, Takeda K, Tsuruya K, Miura S, Toyonaga J, Nakashita S, Furushou M, Mukai H, Mutou Y, Komaki T, Takae K, Yasunaga C.

Case Rep Nephrol Urol. 2012 Jul;2(2):138-44. doi: 10.1159/000343247. Epub 2012 Sep 24.

17.

Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.

Kim SU, Chon YE, Lee CK, Park JY, Kim DY, Han KH, Chon CY, Kim S, Jung KS, Ahn SH.

Yonsei Med J. 2012 Mar;53(2):328-36. doi: 10.3349/ymj.2012.53.2.328.

18.

Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis.

Havey TC, Fowler RA, Daneman N.

Crit Care. 2011;15(6):R267. doi: 10.1186/cc10545. Epub 2011 Nov 15. Review.

19.

Diagnosis and therapy of ascites in liver cirrhosis.

Biecker E.

World J Gastroenterol. 2011 Mar 14;17(10):1237-48. doi: 10.3748/wjg.v17.i10.1237.

20.

Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis.

Riggio O, Angeloni S.

World J Gastroenterol. 2009 Aug 21;15(31):3845-50.

Supplemental Content

Support Center